scholarly journals Association of blood cadmium levels in pregnant women with infant birth size and small for gestational age infants: The Japan Environment and Children's study

2020 ◽  
Vol 191 ◽  
pp. 110007
Author(s):  
Hidekuni Inadera ◽  
Ayako Takamori ◽  
Kenta Matsumura ◽  
Akiko Tsuchida ◽  
Zheng-Guo Cui ◽  
...  
Author(s):  
Daniel Massamatsu Pianovski Kato ◽  
Liziane Lorusso ◽  
Rafael Frederico Bruns ◽  
Elisa Chicareli Pinhat ◽  
Natália Roberta Andrade Dalla Costa ◽  
...  

2009 ◽  
Vol 72 (1) ◽  
pp. 15-24 ◽  
Author(s):  
Wietske A. Ester ◽  
Joyce B. van Meurs ◽  
Nicolette J. Arends ◽  
André G. Uitterlinden ◽  
Maria A. de Ridder ◽  
...  

2020 ◽  
Vol 79 (OCE2) ◽  
Author(s):  
Urszula Sliwka ◽  
Katarzyna Przybylowicz ◽  
Neil MacLachlan ◽  
Jakub Morze ◽  
Anna Danielewicz ◽  
...  

AbstractThe role of nutritional status of pregnant women and birth outcomes is ambiguous. Recent studies show that pre-pregnancy body weight is equally important as weight gain during pregnancy. Body mass index (BMI) is the most accessible and easy to check a nutritional status index, which may help to control the gestation and predict infant health outcome. This study aimed to examine the associations between pre-pregnancy body mass index and the infant birth parameters. A presented observational study was offered to 200 pregnant women from Antenatal Clinic at Jersey General Hospital in 2017. Total number of 83 women agreed to take part in this project. Diet, lifestyle, socio-economic, and demographic data were obtained from participants. Delivery and birth data were taken from hospital records. Offspring feeding data and selected anthropometric measurements for mothers and their newborns were also collected. Differences between BMI for delivery type and way of feeding were verified with chi-square test. Differences and correlation between maternal BMI and newborn outcomes were verified with Kruskal-Wallis’ test and Spearman's rank test. Mean BMI of mothers included to the study was 22.8 ± 4.4 with mean weight 61.9 ± 11.6. Before pregnancy BMI was normal in 67% women and about 23% was overweight or obese. We do not observed differences between delivery type and way of feeding during first 48 hours, and women in BMI categories. Also no differences and correlation were observed for the Apgar score, gestational age of birth, and newborn's weight and length at birth. However, newborn weight correlated with newborn length (r = 0.433) and gestational age (r = 0.568) at birth. Concluding, the maternal pre-pregnancy BMI was not correlated with type of delivery, way of feeding and newborn outcomes. Previous studies show that high pre-pregnancy maternal BMI may be associated with adverse offspring outcomes at birth and later life. Future extended research is needed to explain these relations, with inclusion of the specific factors as maternal diet, lifestyle and ethnicity.


PLoS ONE ◽  
2018 ◽  
Vol 13 (1) ◽  
pp. e0191389 ◽  
Author(s):  
Ingrid J. M. Snijdewind ◽  
Colette Smit ◽  
Mieke H. Godfried ◽  
Rachel Bakker ◽  
Jeannine F. J. B. Nellen ◽  
...  

2018 ◽  
Vol 7 (10) ◽  
pp. 1096-1104 ◽  
Author(s):  
Robert Rapaport ◽  
Peter A Lee ◽  
Judith L Ross ◽  
Paul Saenger ◽  
Vlady Ostrow ◽  
...  

Growth hormone (GH) is used to treat short stature and growth failure associated with growth disorders. Birth size and GH status variably modulate response to GH therapy. The aim of this study was to determine the effect of birth size on response to GH therapy, and to determine the impact of GH status in patients born small for gestational age (SGA) on response to GH therapy. Data from the prospective, non-interventional American Norditropin Studies: Web-Enabled Research (ANSWER) Program was analyzed for several growth outcomes in response to GH therapy over 3 years. GH-naïve children from the ANSWER Program were included in this analysis: SGA with peak GH ≥10 ng/mL (20 mIU/L), SGA with peak GH <10 ng/mL (20 mIU/L), isolated growth hormone deficiency (IGHD) born SGA, IGHD not born SGA and idiopathic short stature. For patients with IGHD, those who did not meet criteria for SGA at birth showed greater improvements in height SDS and BMI SDS than patients with IGHD who met criteria for SGA at birth. For patients born SGA, response to GH therapy varied with GH status. Therefore, unlike previous guidelines, we recommend that GH status be established in patients born SGA to optimize GH therapy.


Sign in / Sign up

Export Citation Format

Share Document